SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 AC Immune SA 6-K 3/30/20 4:604K Davis Polk & … LLP 01/FA |
Document/Exhibit Description Pages Size 1: 6-K Current Report by a Foreign Issuer HTML 11K 2: EX-99.1 Miscellaneous Exhibit HTML 61K 3: EX-99.2 Miscellaneous Exhibit HTML 108K 4: EX-99.3 Miscellaneous Exhibit HTML 91K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2020
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified in its charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F |
☒ |
Form 40-F | ☐ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes | ☐ | No |
☒ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes | ☐ | No |
☒ |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AC IMMUNE SA | |||
By: | /s/ Andrea Pfeifer | ||
Name: | Andrea Pfeifer | ||
Title: | Chief Executive Officer |
By: | /s/ Joerg Hornstein | ||||
Name: | Joerg Hornstein | ||||
Title: | Chief Financial Officer | ||||
Date: | March 30, 2020 |
C: 2
Exhibit Index
Exhibit Number |
Description |
99.1 | Press Release dated March 30, 2020 |
99.2 | 2019 Statutory Annual Report |
99.3 | 2019 Compensation Report |
3
This ‘6-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 3/30/20 | 20-F | ||
List all Filings |